bioRxiv · 10.1101/2023.07.28.550922
Quantification of circulating tumor DNA using deep learning
Abstract
Quantification of circulating tumor DNA (ctDNA) levels in blood enables non-invasive surveillance of cancer progression. Fragle is an ultra-fast deep learning-based method for ctDNA quantification directly from cell-free DNA fragment length profiles. We developed Fragle using low-pass whole genome sequence (lpWGS) data from multiple cancer types and healthy control cohorts, demonstrating high accuracy, and improved lower limit of detection in independent cohorts as compared to existing tumor-naive methods. Uniquely, Fragle is also compatible with targeted sequencing data, exhibiting high accuracy across both research and commercial targeted gene panels. We used this method to study longitudinal plasma samples from colorectal cancer patients, identifying strong concordance of ctDNA dynamics and treatment response. Furthermore, prediction of minimal residual disease in resected lung cancer patients demonstrated significant risk stratification beyond a tumor-naive gene panel. Overall, Fragle is a versatile, fast, and accurate method for ctDNA quantification with potential for broad clinical utility.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jacobsen Skanderup, A., Zhu, G., Rahman, C., Getty, V., Baruah, P., Carrie, H., Lim, A., Guo, Y. A., Poh, Z., Sim, N., Abdelmoneim, A., Cai, Y., Ho, D., Thangaraju, S., Poon, P., Lau, Y., Gan, A., Ng, S., Odinokov, D., Koo, S.-L., Chong, D., Tay, B., Tan, T., Yap, Y., Chok, A., Ng, M., Tan, P., Tan, D., Wong, L., Wong, P., Tan, I.. 2023-07-28. Quantification of circulating tumor DNA using deep learning. https://doi.org/10.1101/2023.07.28.550922
Cite the original work for its findings. Save a collection to share your selection of sources.